These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16352712)

  • 1. Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design.
    Li M; Laco GS; Jaskolski M; Rozycki J; Alexandratos J; Wlodawer A; Gustchina A
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18332-7. PubMed ID: 16352712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV-1 PR.
    Selvaraj C; Singh P; Singh SK
    J Mol Recognit; 2014 Dec; 27(12):696-706. PubMed ID: 25319617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease.
    Satoh T; Li M; Nguyen JT; Kiso Y; Gustchina A; Wlodawer A
    J Mol Biol; 2010 Aug; 401(4):626-41. PubMed ID: 20600105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Privileged Structures Meet Human T-Cell Leukemia Virus-1 (HTLV-1): C2-Symmetric 3,4-Disubstituted Pyrrolidines as Nonpeptidic HTLV-1 Protease Inhibitors.
    Kuhnert M; Blum A; Steuber H; Diederich WE
    J Med Chem; 2015 Jun; 58(11):4845-50. PubMed ID: 26000468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protease of human T-cell leukemia virus type-1 is a potential therapeutic target.
    Tözsér J; Weber IT
    Curr Pharm Des; 2007; 13(12):1285-94. PubMed ID: 17504236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cells.
    Demir A; Oguariri RM; Magis A; Ostrov DA; Imamichi T; Dunn BM
    Antivir Ther; 2012; 17(5):883-92. PubMed ID: 22436331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
    Tözsér J; Zahuczky G; Bagossi P; Louis JM; Copeland TD; Oroszlan S; Harrison RW; Weber IT
    Eur J Biochem; 2000 Oct; 267(20):6287-95. PubMed ID: 11012683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.
    Sperka T; Miklóssy G; Tie Y; Bagossi P; Zahuczky G; Boross P; Matúz K; Harrison RW; Weber IT; Tözsér J
    J Gen Virol; 2007 Jul; 88(Pt 7):2052-2063. PubMed ID: 17554040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for HTLV-1 protease inhibition by the HIV-1 protease inhibitor indinavir.
    Kuhnert M; Steuber H; Diederich WE
    J Med Chem; 2014 Jul; 57(14):6266-72. PubMed ID: 25006983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.
    Kádas J; Weber IT; Bagossi P; Miklóssy G; Boross P; Oroszlan S; Tözsér J
    J Biol Chem; 2004 Jun; 279(26):27148-57. PubMed ID: 15102858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding HTLV-I protease.
    Shuker SB; Mariani VL; Herger BE; Dennison KJ
    Chem Biol; 2003 May; 10(5):373-80. PubMed ID: 12770819
    [No Abstract]   [Full Text] [Related]  

  • 12. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
    Hrusková-Heidingsfeldová O; Bláha I; Urban J; Strop P; Pichová I
    Leukemia; 1997 Apr; 11 Suppl 3():45-6. PubMed ID: 9209292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.
    Saiga A; Tanaka T; Orita S; Sato A; Sato S; Hachisu T; Abe K; Kimura Y; Kondo Y; Fujiwara T
    Arch Virol; 1993; 128(3-4):195-210. PubMed ID: 8435041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular replacement with pseudosymmetry and model dissimilarity: a case study.
    Jaskólski M; Li M; Laco G; Gustchina A; Wlodawer A
    Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):208-15. PubMed ID: 16421452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrates and inhibitors of human T-cell leukemia virus type I protease.
    Ding YS; Rich DH; Ikeda RA
    Biochemistry; 1998 Dec; 37(50):17514-8. PubMed ID: 9860866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic.
    Maegawa H; Kimura T; Arii Y; Matsui Y; Kasai S; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5925-9. PubMed ID: 15501070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
    Abdel-Rahman HM; Kimura T; Hidaka K; Kiso A; Nezami A; Freire E; Hayashi Y; Kiso Y
    Biol Chem; 2004 Nov; 385(11):1035-9. PubMed ID: 15576323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.
    Kádas J; Boross P; Weber IT; Bagossi P; Matúz K; Tözsér J
    Biochem J; 2008 Dec; 416(3):357-64. PubMed ID: 18636969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network.
    Rücker P; Horn AH; Meiselbach H; Sticht H
    J Mol Model; 2011 Oct; 17(10):2693-705. PubMed ID: 21279524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the protonation states of the catalytic residues in apo and substrate-bound human T-cell leukemia virus type 1 protease.
    Ma S; Vogt KA; Petrillo N; Ruhoff AJ
    Comput Biol Chem; 2015 Jun; 56():61-70. PubMed ID: 25889320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.